Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06334549

A Prospective Study of Vasopressor on Cerebral Oxygenation During General Anesthesia

Effects of Vasopressor on Cerebral Oxygenation During General Anesthesia in Abdominal Surgery

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
180 (estimated)
Sponsor
Dalian Municipal Central Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to investigate whether norepinephrine(N), phenylephrine(P) or ephedrine(E) have different effect on cerebral oxygenation in abdominal surgery with propofol or sevoflurane.

Detailed description

This study was a single-center, randomized, double-blinded, controlled trial. First, the effects of E, P, or N on cerebral oxygen saturation(rScO2) under general anesthesia in abdominal surgery were studied. Patients with abdominal surgery were evaluated using near-infrared spectroscopy. Continual changes in systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial blood pressure (MAP), heart rate (HR), stroke volume (SV), cardiac output (CO) and systemic vascular resistance (SVR) will be measured with LiDCO rapidV3 monitoring system. To investigate the individualized therapeutic options \& specific mechanisms of the three vasopressors on rScO2 and CO.

Conditions

Interventions

TypeNameDescription
DRUGEphedrine-Pafter induction of anesthesia, use total intravenous anesthesia maintained with propofol
DRUGPhenylephrine-Pafter induction of anesthesia, use total intravenous anesthesia maintained with propofol
DRUGNorepinephrine-Pafter induction of anesthesia, use total intravenous anesthesia maintained with propofol
DRUGEphedrine-Safter induction of anesthesia, use inhalation anesthesia maintained with sevoflurane
DRUGPhenylephrine-Safter induction of anesthesia, use inhalation anesthesia maintained with sevoflurane
DRUGNorepinephrine-Safter induction of anesthesia, use inhalation anesthesia maintained with sevoflurane

Timeline

Start date
2024-03-05
Primary completion
2025-12-05
Completion
2025-12-05
First posted
2024-03-28
Last updated
2024-11-06

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06334549. Inclusion in this directory is not an endorsement.